Basic Information |
|
| Product Name: | VERAPAMIL HYDROCHLORIDE |
| CAS: | 152-11-4 ;52-53-9 ;23313-68-0 |
| English Synonyms: | 2-(3,4-DIMETHOXYPHENYL)-5-([2-(3,4-DIMETHOXYPHENYL)ETHYL]METHYLAMINO)-2-(METHYLETHYL)PENTANENITRILE, CHLORIDE ; 2-(3,4-DIMETHOXYPHENYL)-5-([2-(3,4-DIMETHOXYPHENYL)ETHYL](METHYL)AMINO)-2-(PROPAN-2-YL)PENTANENITRILE HYDROCHLORIDE ; VERAPAMIL HYDROCHLORIDE ; VERAPAMIL (HYDROCHLORIDE) ; IPROVERATRIL ; CALAN HYDROCHLORIDE ; IPROVERATRIL HYDROCHLORIDE ; 5-((3,4-DIMETHOXYPHENETHYL)(METHYL)AMINO)-2-(3,4-DIMETHOXYPHENYL)-2-ISOPROPYLPENTANENITRILE HYDROCHLORIDE ; VIPROVERATRIL ; ISOPTIN ; (+/-)-VERAPAMIL HYDROCHLORIDE ; 5-[N-(3,4-DIMETHOXYPHENYLETHYL)METHYLAMINO]-2-(3,4-DIMETHOXYPHENYL)-2-ISOPROPYLVALERONITRILE HYDROCHLORIDE ; (±)-VERAPAMIL HYDROCHLORIDE ; ARPAMYL HYDROCHLORIDE ; ALPHA-(3-((2-(3,4-DIMETHOXYPHENYL)ETHYL)METHYLAMINO)PROPYL)-3,4-DIMETHOXY-ALPHA-(1-METHYLETHYL)-BENZENEACETONITRILE HYDROCHLORIDE ; 5-((3,4-DIMETHOXYPHENETHYL)METHYLAMINO)-2-(3,4-DIMETHOXYPHENYL)-2-ISOPROPYLVALERONITRILE HYDROCHLORIDE ; CALAN ; VERAPAMIL HCL ; BENZENEACETONITRILE, ALPHA-[3-[[2-(3,4-DIMETHOXYPHENYL)ETHYL]METHYLAMINO]PROPYL]-3,4-DIMETHOXY-A-(1-METHYLETHYL)-, MONOHYDROCHLORIDE ; 2-(3,4-DIMETHOXYPHENYL)-5-[[2-(3,4-DIMETHOXYPHENYL)ETHYL](METHYL)AMINO]-2-ISOPROPYLPENTANENITRILE HYDROCHLORIDE ; ISOPTIN HYDROCHLORIDE |
| MDL Number.: | MFCD00055208 |
| H bond acceptor: | 6 |
| H bond donor: | 0 |
| Smile: | CC(C)C(CCCN(C)CCc1ccc(c(c1)OC)OC)(C#N)c2ccc(c(c2)OC)OC.Cl |
| InChi: | InChI=1S/C27H38N2O4.ClH/c1-20(2)27(19-28,22-10-12-24(31-5)26(18-22)33-7)14-8-15-29(3)16-13-21-9-11-23(30-4)25(17-21)32-6;/h9-12,17-18,20H,8,13-16H2,1-7H3;1H |
| InChiKey: | InChIKey=DOQPXTMNIUCOSY-UHFFFAOYSA-N |
Property |
|
| Melting Point: | 142 DEG C (DEC)(LIT)/140-144℃ |
| Comments: | BIOCHEM/PHYSIOL ACTIONS: ALPHA1-ADRENOCEPTOR ANTAGONIST BIOCHEM/PHYSIOL ACTIONS: L-TYPE CALCIUM CHANNEL BLOCKER. BLOCKS L-TYPE CA2+ CHANNELS IN SMOOTH AND CARDIAC MUSCLE, INDUCES APOPTOSIS OF HUMAN PRIMARY AND METASTATIC COLON ADENOCARCINOMA CELLS IN VITRO. DRUG RESISTANCE REVERSAL AGENT ACTING ON PGP, EG DECREASE RENAL TUBULE ELIMINATION OF DIGOXIN. INCREASES BASAL ATPASE ACTIVITY OF PGP. SUBSTRATE OF CYP3A4 AND CYP2C6 RIDADR: UN 2811 6.1/PG 3 RTECS: YV8320000 UNSPSC: 12352100 WGK: 3 |
Safety information |
|
| Symbol: |
GHS06
|
| Signal word: | Danger |
| Hazard statements: | H301 + H311 + H331 |
| Precautionary statements: | P261-P280-P301 + P310-P311 |
| hazard symbol: | T |
| Risk Code: | R:23/24/25 |
| Safe Code: | S:36/37-45 |
| UN Code: | 2811 |
| WGK Germany: | 3 |
* If the product has intellectual property rights, a license granted is must or contact us.
2010-2025 © Chemical Cloud Database. ALL Rights Reserved.浙ICP备11020424号-1
浙公网安备 33010802004002号